Iressa (gefitinib, ZD1839)

IRESSA (gefitinib) is an epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitor, that acts to block signals for cancer cell growth and survival in non-small cell lung cancer.

SPC/PILFor Summary of Product Characteristics and Patient Information Leaflet click this link



Approval ID: 155,827.011
Date of preparation: June 2014

We work with charity Cancer Research UK on a number of research and delivery projects, so that together, we can do more to beat cancer.